Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO)
$46.56 USD
Updated Jul 16 12:47pm
Add AGIO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
AGIO News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 15, 2019
Best & Worst Performing Small Cap Stocks for July 15, 2019
Best & Worst Performing Mid Cap Stocks for July 15, 2019
Best & Worst Performing Large Cap Stocks for July 15, 2019
Best & Worst Performing Mega Cap Stocks for July 15, 2019
View All Top StoriesAgios Pharmaceuticals, Inc. (AGIO) Company Bio
Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. The company was founded in 2007 and is based in Cambridge, Massachusetts.
AGIO Stock Chart More Charts
AGIO Price/Volume Stats
| Current price | $46.56 |
| Prev. close | $46.17 |
| Day low | $45.75 |
| Day high | $46.94 |
| 50-day MA | $48.66 |
| 200-day MA | $57.34 |
| 52-week high | $94.39 |
| 52-week low | $41.63 |
| Volume | 342,085 |
| Avg. volume | 510,626 |
| Dividend yield | N/A |
| Market Cap | 2.73B |
AGIO Returns
| 1-mo | -3.10% |
| 3-mo | -17.36% |
| 6-mo | -17.17% |
| 1-year | -48.27% |
| 3-year | 11.55% |
| 5-year | 40.20% |
| YTD | 0.98% |
| 2018 | -19.35% |
| 2017 | 37.00% |
| 2016 | -35.72% |
| 2015 | -42.06% |
| 2014 | 367.81% |
Loading social stream, please wait...